GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ANIP
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for ANI Pharmaceuticals stock after losing 1.37%
(Updated on Apr 18, 2024)

Sell candidate since Apr 15, 2024 Loss -2.59% PDF

The ANI Pharmaceuticals stock price fell by -1.37% on the last day (Thursday, 18th Apr 2024) from $65.48 to $64.58. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 2.40% from a day low at $64.43 to a day high of $65.98. The price has fallen in 9 of the last 10 days and is down by -4.95% for this period. Volume has increased on the last day by 61 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 180 thousand shares were bought and sold for approximately $11.63 million.

Given the current short-term trend, the stock is expected to rise 28.30% during the next 3 months and, with a 90% probability hold a price between $82.86 and $94.45 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ANIP Signals & Forecast

There are few to no technical positive signals at the moment. The ANI Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $66.27 and $67.26. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, March 27, 2024, and so far it has fallen -7.33%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for ANI Pharmaceuticals stock

On the downside, the stock finds support just below today's level from accumulated volume at $60.25 and $56.51. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, ANI Pharmaceuticals finds support just below today's level at $60.25. If this is broken, then the next support from accumulated volume will be at $56.51 and $55.02.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $1.54 (2.40%) between high and low. For the last week, the stock has had daily average volatility of 2.09%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ANIP) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect ANI Pharmaceuticals to open at $65.00, and during the day (based on 14 day Average True Range), to move between $63.09 and $66.07, which gives a possible trading interval of +/-$1.49 (+/-2.30%) up or down from last closing price. If ANI Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 4.61% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $66.00 (2.20%) than the support at $60.25 (6.70%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is ANI Pharmaceuticals stock A Buy?

The ANI Pharmaceuticals stock holds several negative signals and despite the positive trend, we believe ANI Pharmaceuticals will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.036 Sell Candidate Unchanged

Predicted Opening Price for ANI Pharmaceuticals of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$65.00 ( 0.643%) $64.58

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ANIP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 66.54 3.03 %
R2 65.95 2.12 %
R1 65.59 1.56 %
Current price: 64.58
Support S1 64.40 -0.271 %
S2 64.04 -0.84 %
S3 63.45 -1.75 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 67.87 5.09 %
R2 67.67 4.78 %
R1 66.00 2.20 %
Current price 64.58
Support S1 60.25 -6.70%
S2 56.51 -12.50%
S3 55.02 -14.80%

FAQ

What is the symbol for ANI Pharmaceuticals Stock and on which exchange is it traded?
The symbol for ANI Pharmaceuticals is ANIP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ANI Pharmaceuticals Stock?
The ANI Pharmaceuticals stock holds several negative signals and despite the positive trend, we believe ANI Pharmaceuticals will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy ANI Pharmaceuticals Stock?
ANI Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ANI Pharmaceuticals Stock.

What's the current price of ANI Pharmaceuticals Stock?
As of the end of day on the 2024-04-18, the price of an ANI Pharmaceuticals (ANIP) share was $64.58.

What is the 52-week high and low for ANI Pharmaceuticals Stock?
The 52-week high for ANI Pharmaceuticals Stock is $70.81 and the 52-week low is $36.99.

What is the market capitalization of ANI Pharmaceuticals Stock?
As of the 2024-04-18, the market capitalization of ANI Pharmaceuticals is 1.355B.

When is the next earnings date for ANI Pharmaceuticals?
The upcoming earnings date for ANI Pharmaceuticals is May 13, 2024.
Click to get the best stock tips daily for free!

About ANI Pharmaceuticals

ANI Pharmaceuticals ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development a... ANIP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT